However, in some cases this mechanism eliminates a T-cell subset with a necessary function (e.g., CD4+ helper T cells in CD4 CAR T cells), which may reduce the anti-tumor activity of these CAR T cells. The gene discussed is CD4; the disease is neoplasm.